- Home
- RIVN vs ILMN Comparison
RIVN vs ILMN Comparison
Compare RIVN & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RIVN | ILMN |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.1B | 20.4B |
| IPO Year | 2021 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RIVN | ILMN |
|---|---|---|
| Price | $15.26 | $122.23 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 23 | 17 |
| Target Price | $17.71 | ★ $124.24 |
| AVG Volume (30 Days) | ★ 26.8M | 2.2M |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.54 | ★ 170.87 |
| EPS | N/A | ★ 5.45 |
| Revenue | ★ $5,387,000,000.00 | $4,343,000,000.00 |
| Revenue This Year | $34.38 | $6.56 |
| Revenue Next Year | $62.45 | $5.49 |
| P/E Ratio | ★ N/A | $22.55 |
| Revenue Growth | ★ 8.39 | N/A |
| 52 Week Low | $10.36 | $68.70 |
| 52 Week High | $22.69 | $155.53 |
Technical Indicators
Market Signals| Indicator | RIVN | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 42.63 |
| Support Level | $13.72 | $114.88 |
| Resistance Level | $16.65 | $126.00 |
| Average True Range (ATR) | 0.90 | 4.09 |
| MACD | 0.14 | 0.20 |
| Stochastic Oscillator | 38.47 | 43.91 |
Price Performance
Historical ComparisonAbout RIVN Rivian Automotive Inc.
Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck and full-size SUV and a delivery van. The company also plans to begin selling a midsize SUV in 2026. Total deliveries were nearly 52,000 in 2024. Rivian is also developing autonomous driving software to be used in its vehicles.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.